Р. В. Орлова

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Robot-assisted retroperitoneal lymph node dissection for stage IIA–IIB testicular germ cell tumor2026
• The role of a specialized hospital in the treatment of testicular germ cell tumors (literature review, case studies)2026
• Ceralasertib as second- or third-line therapy for advanced or metastatic non-small-cell lung cancer without actionable genomic alterations (LOTOS): a multicenter, single-arm, phase 2 trial2026
• The first domestic combination of nurulimab + prolgolimab: from clinical development and economic analysis to real-world use in disseminated melanoma2026
• Predictive Factors for Infectious Complications Following Immediate and Delayed Reconstruction in Breast Cancer Patients2026
• Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study2024 · аннотациясвернуть

  PURPOSE Treatment options are limited for patients with previously treated metastatic colorectal cancer (mCRC). In the LEAP-017 study, we evaluate whether lenvatinib in combination with pembrolizumab improves outcomes…

• Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study2024 · аннотациясвернуть

  PURPOSE To compare giredestrant and physician's choice of endocrine monotherapy (PCET) for estrogen receptor–positive, HER2-negative, advanced breast cancer (BC) in the phase II acelERA BC study (ClinicalTrials.gov…

• Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial2023